Curaleaf Holdings, Inc.
General ticker "CURLF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.2B (TTM average)
Curaleaf Holdings, Inc. follows the US Stock Market performance with the rate: 50.5%.
Estimated limits based on current volatility of 3.9%: low 2.42$, high 2.62$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.93$, 2.61$]
- 2025-12-31 to 2026-12-31 estimated range: [0.81$, 2.17$]
Financial Metrics affecting the CURLF estimates:
- Positive: with PPE of -8.4 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 1.50
- Positive: Operating cash flow per share per price, % of 14.46 > 13.24
- Positive: 18.93 < Shareholder equity ratio, % of 29.20 <= 41.86
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
Short-term CURLF quotes
Long-term CURLF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,224.88MM | $1,371.33MM | $1,278.33MM |
| Operating Expenses | $1,162.47MM | $1,327.66MM | $1,259.10MM |
| Operating Income | $62.41MM | $43.67MM | $19.23MM |
| Non-Operating Income | $-145.47MM | $-170.32MM | $-131.21MM |
| Interest Expense | $88.84MM | $100.38MM | $100.62MM |
| Income(Loss) | $-83.06MM | $-126.65MM | $-111.98MM |
| Taxes | $171.74MM | $116.69MM | $93.86MM |
| Profit(Loss)* | $-376.93MM | $-286.35MM | $-226.73MM |
| Stockholders Equity | $1,279.12MM | $1,045.27MM | $860.70MM |
| Inventory | $234.68MM | $214.81MM | $220.52MM |
| Assets | $3,413.01MM | $3,080.73MM | $2,947.78MM |
| Operating Cash Flow | $46.40MM | $75.26MM | $162.57MM |
| Capital expenditure | $138.36MM | $70.30MM | $98.15MM |
| Investing Cash Flow | $-228.62MM | $-78.69MM | $-93.83MM |
| Financing Cash Flow | $50.54MM | $-67.02MM | $-54.24MM |
| Earnings Per Share** | $-0.53 | $-0.40 | $-0.31 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.